Vesalius Biocapital and Faber Ventures

The round was led by Todd Cozzens and had participation from existing investors Khosla Ventures, Founders Fund, Green Innovations, Vesalius Biocapital and Faber.
SWORD Health closes $25 million Series B round to accelerate company growth
By Mallory Hackett | 01:05 pm | January 29, 2021
The round was led by Todd Cozzens and had participation from existing investors Khosla Ventures, Founders Fund, Green Innovations, Vesalius Biocapital and Faber.